Ashraf Kariminik

Dr. Ashraf Kariminik

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Immunology Letters
Verified
Journal Article
Closed access
AKAshraf Kariminik
Ashraf Kariminik
MBMajid Baseri-Salehi
Majid Baseri-Salehi
BKBabak Kheirkhah
Babak Kheirkhah

18 September 2017 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
BDBanafsheh Douzandeh-Mobarrez
Banafsheh Douzandeh-Mobarrez
AKAshraf Kariminik
Ashraf Kariminik

1 September 2018 in Allergologia et Immunopathologia
Verified
Journal Article
Closed access
MNM. Naghib
M. Naghib
MHM. Hatam-Jahromi
M. Hatam-Jahromi
MNM. Niktab
M. Niktab
RAR. Ahmadi
R. Ahmadi
AKAshraf Kariminik
Ashraf Kariminik
Mycoplasma pneumoniae is an intracellular bacterium leading to several complications in humans. M. pneumoniae is cleared in some cases and induces complications in others. The main responsible mechanisms regarding the controversy are yet to be cleared. Toll-like receptors (TLRs) are the important cell membrane and intracellular receptors which recognize a wide range of microbial macromolecules. The roles of TLRs in the eradication of several pathogens and also induction of their related complications have been demonstrated. This review article presents recent data about the roles of TLRs in the induction of immune responses which lead to M. pneumoniae eradication and related complications.

1 March 2016 in Viral Immunology
Verified
Journal Article
Closed access
AKAshraf Kariminik
Ashraf Kariminik
RYRamin Yaghobi
Ramin Yaghobi
SDShahriar Dabiri
Shahriar Dabiri
Recent information demonstrated that BK virus reactivation is a dominant complication after kidney transplantation, which occurs because of immunosuppression. BK virus reactivation is the main reason of transplanted kidney losing. Immune response against BK virus is the major inhibitor of the virus reactivation. Therefore, improving our knowledge regarding the main parameters that fight against BK viruses can shed light on to direct new treatment strategies to suppress BK infection. Innate immunity consists of numerous cell systems and also soluble molecules, which not only suppress virus replication, but also activate adaptive immunity to eradicate the infection. Additionally, it appears that immune responses against reactivated BK virus are the main reasons for induction of BK virus-associated nephropathy (BKAN). Thus, improving our knowledge regarding the parameters and detailed mechanisms of innate immunity and also the status of innate immunity of the patients with BK virus reactivation and its complications can introduce new prospective strategies to either prevent or as therapy of the complication. Therefore, this review was aimed to collate the most recent data regarding the roles played by innate immunity against BK virus and also the status of innate immunity in the patients with reactivation BK virus and BKAN.

3 June 2021 in Virology Journal
Verified
Journal Article
Open access
PDF file
MMMohammad Hassan Mohammadi
Mohammad Hassan Mohammadi
AKAshraf Kariminik
Ashraf Kariminik
It has been reported that polyomaviruses are the microbes which can be a cause of several human pathological conditions including cancers, nephropathy, progressive multifocal leukoencephalopathy and gynaecological disease. Although investigators proposed some mechanisms used by the viruses to induce the disorders, the roles played by chemokines in the pathogenesis of polyomaviruses infections are yet to be clarified. This review article investigated recent studies regarding the roles played by chemokines in the pathogenesis of the polyomaviruses infections. The research in the literature revealed that CXC chemokines, including CXCL1, CXCL5, CXCL8, CXCL9, CXCL10, CXCL11, CXCL12 and CXCL16, significantly participate in the pathogenesis of polyomaviruses. CC chemokines, such as CCL2, CCL5 and CCL20 also participate in the induction of the pathological conditions. Therefore, it appears that CXC chemokines may be considered as the strategic factors involved in the pathogenesis of polyomaviruses.

1 February 2022 in Viral Immunology
Verified
Journal Article
Closed access
MNMaryam Naghib
Maryam Naghib
AKAshraf Kariminik
Ashraf Kariminik
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
The immune system of active and inactive chronic hepatitis B, as prolonged forms of hepatitis B, is unable to eradicate hepatitis B virus (HBV) from the infected hepatocytes completely. Toll-like receptors (TLRs) play key roles in the viral recognition and promotion of appropriate immune responses. The molecules also participate in the alteration of the target cell functions and transformation. TLR2 is the unique molecule that makes either homodimer or heterodimer with TLR1 and 6 and shows variable roles against viral infections. Therefore, it has been hypothesized that TLR2 may participate in both immune response against HBV and induction of the virus-related hepatic complications. The studies confirm the hypothesis and revealed that TLR2 is not only one of the main molecules altering the course of HBV infection, but also plays key roles in induction of hepatocellular carcinoma (HCC) and liver cirrhosis. However, recent studies demonstrated that the molecule can fight against HCC and liver cirrhosis. Collectively, it appears that nutrition habits, TLR2 gene polymorphisms, gut microbiome, HBV antigens, and activation of other receptors may play key roles in the determination of TLR2 functions.